Healionics Corporation

Healionics Corporation

Other, 2121 North 35th St, Seattle, Washington, 98103, United States, 1-10 Employees

healionics.com

  • LinkedIn

phone no Phone Number: +14*********

Who is HEALIONICS CORPORATION

Healionics is a clinical-stage company addressing the critical need for safer, more reliable means of bloodstream access to perform dialysis in patients with kidney failure. Our STARgraft...

Read More

map
  • 2121 North 35th St, Seattle, Washington, 98103, United States Headquarters: 2121 North 35th St, Seattle, Washington, 98103, United States
  • 2007 Date Founded: 2007
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Other

SIC SIC Code: 8731 | NAICS Code: 561110 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from HEALIONICS CORPORATION

Healionics Corporation Org Chart and Mapping

Employees

Helen Hsu

Director of Business Operations

Molly Daigle

Biomaterials Manufacturing Engineer I

Adrienne Oda

Lead R&D and Quality Engineer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Healionics Corporation

Answer: Healionics Corporation's headquarters are located at 2121 North 35th St, Seattle, Washington, 98103, United States

Answer: Healionics Corporation's phone number is +14*********

Answer: Healionics Corporation's official website is https://healionics.com

Answer: Healionics Corporation's revenue is Under $1 Million

Answer: Healionics Corporation's SIC: 8731

Answer: Healionics Corporation's NAICS: 561110

Answer: Healionics Corporation has 1-10 employees

Answer: Healionics Corporation is in Other

Answer: Healionics Corporation contact info: Phone number: +14********* Website: https://healionics.com

Answer: Healionics is a clinical-stage company addressing the critical need for safer, more reliable means of bloodstream access to perform dialysis in patients with kidney failure. Our STARgraft vascular graft (synthetic blood vessel) is designed to resist the problems of infection and occlusion suffered by current devices. We also have an exciting product pipeline based on our platform STAR biomaterial, which has a unique ability to prevent two serious problems that affect all implantable devices: scarring and infection. The company is currently conducting human studies of STARgraft and has 33 patents issued or pending.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access